Lifecore Biomedical, Inc. (LFCR)
USD 6.23
(-1.74%)
USD 6.23
(-1.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 128.26 Million | 103.26 Million | 185.78 Million | 544.16 Million | 590.36 Million | 557.55 Million |
| Cost of Revenue | 86.41 Million | 75.97 Million | 135.23 Million | 462.68 Million | 515.37 Million | 476.55 Million |
| Gross Profit | 41.85 Million | 27.29 Million | 50.55 Million | 81.47 Million | 74.98 Million | 81 Million |
| Operating Expenses | 49.03 Million | 51.25 Million | 50.47 Million | 75.58 Million | 83.28 Million | 75.52 Million |
| Selling, General and Administrative Expenses | 40.46 Million | 43.01 Million | 42.63 Million | 65.36 Million | 72.18 Million | 64.06 Million |
| Research and Development Expenses | 8.57 Million | 8.24 Million | 7.84 Million | 10.22 Million | 11.09 Million | 11.46 Million |
| Other Expenses | - | -729 Thousand | 3.29 Million | -12.79 Million | -4.39 Million | 1.6 Million |
| Cost and Expenses | 135.44 Million | 127.23 Million | 185.7 Million | 538.27 Million | 598.66 Million | 552.08 Million |
| Operating Income | 9.33 Million | -26.08 Million | 3.45 Million | -6.86 Million | -8.29 Million | -8.01 Million |
| Interest Expense | 18.09 Million | 18.18 Million | 17.26 Million | 15.34 Million | 9.6 Million | 5.23 Million |
| Income Tax Expense | 183 Thousand | 301 Thousand | -5.83 Million | -7.8 Million | -13.11 Million | 1.51 Million |
| Earnings before Tax | 9.51 Million | -68.7 Million | -51.92 Million | -40.46 Million | -51.3 Million | 3.64 Million |
| Net Income | 12.01 Million | -102.19 Million | -46.08 Million | -32.66 Million | -38.19 Million | 2.12 Million |
| Earnings Per Share Basic | 0.39 | -3.41 | -1.56 | -1.12 | -1.31 | 0.07 |
| Earnings Per Share Diluted | 0.33 | -3.41 | -1.56 | -1.12 | -1.31 | 0.07 |
| Weighted Average Shares Outstanding | 30.47 Million | 29.95 Million | 29.46 Million | 29.29 Million | 29.16 Million | 28.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.65 Million | 29.95 Million | 29.46 Million | 29.29 Million | 29.16 Million | 28.6 Million |
| Gross Margin | 0.33 | 0.26 | 0.27 | 0.15 | 0.13 | 0.15 |
| EBIT Margin | 0.01 | -0.11 | 0.11 | 0.02 | -0.02 | 0.01 |
| Profit Margin | 0.09 | -0.99 | -0.25 | -0.06 | -0.06 | 0.00 |
| EBITDA | 812 Thousand | -35.97 Million | 1.96 Million | 13 Million | -7.16 Million | 23.47 Million |
| Earnings Before Tax Margin | 0.07 | -0.25 | 0.02 | -0.01 | -0.01 | -0.01 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 128.26 Million | 37.88 Million | 35.7 Million | 30.15 Million | 24.52 Million | 103.26 Million |
| Cost of Revenue | 86.41 Million | 20.61 Million | 23.81 Million | 20.19 Million | 21.79 Million | 75.97 Million |
| Gross Profit | 41.85 Million | 17.27 Million | 11.89 Million | 9.95 Million | 2.72 Million | 27.29 Million |
| Operating Expenses | 49.03 Million | 14.38 Million | 12.01 Million | 11.28 Million | 11.35 Million | 51.25 Million |
| Selling, General and Administrative Expenses | - | 12.22 Million | 9.84 Million | 9.18 Million | 9.2 Million | - |
| Research and Development Expenses | - | 2.16 Million | 2.17 Million | 2.09 Million | 2.14 Million | - |
| Other Expenses | -3.05 Million | -1.1 Million | -814 Thousand | -967 Thousand | -170 Thousand | -729 Thousand |
| Cost and Expenses | 135.44 Million | 34.99 Million | 35.82 Million | 31.47 Million | 33.14 Million | 127.23 Million |
| Operating Income | -7.18 Million | 2.88 Million | -124 Thousand | -1.32 Million | -8.62 Million | -26.08 Million |
| Interest Expense | 18.09 Million | 5.79 Million | 4.28 Million | 4.07 Million | 3.93 Million | 18.18 Million |
| Income Tax Expense | 183 Thousand | -57 Thousand | 217 Thousand | -65 Thousand | 88 Thousand | 301 Thousand |
| Earnings before Tax | 9.51 Million | -7.14 Million | 15 Million | 14.17 Million | -12.52 Million | -68.7 Million |
| Net Income | 12.01 Million | -7.08 Million | 15.63 Million | 14.21 Million | -10.75 Million | -102.19 Million |
| Earnings Per Share Basic | - | -0.23 | 0.51 | 0.47 | -0.35 | - |
| Earnings Per Share Diluted | - | -0.23 | 0.43 | 0.39 | -0.35 | - |
| Weighted Average Shares Outstanding | 30.47 Million | 30.56 Million | 30.48 Million | 30.45 Million | 30.4 Million | 29.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.65 Million | 30.56 Million | 36.6 Million | 36.41 Million | 30.4 Million | 29.95 Million |
| Gross Margin | 0.33 | 0.46 | 0.33 | 0.33 | 0.11 | 0.26 |
| EBIT Margin | - | 0.11 | 0.12 | 0.03 | -0.26 | - |
| Profit Margin | 0.09 | -0.19 | 0.44 | 0.47 | -0.44 | -0.99 |
| EBITDA | - | 4.28 Million | 4.31 Million | 880 Thousand | -6.45 Million | - |
| Earnings Before Tax Margin | -0.06 | 0.08 | -0.00 | -0.04 | -0.35 | -0.25 |
JSWHL
0I1B
TELO
SBXC
600470
FI